When human stem cells take the shortcut

When human stem cells take the shortcut

Jul 21, 2021

Published by bit.bio

read more
Over £200m invested in Babraham Campus companies in last year – but what lies ahead?

Over £200m invested in Babraham Campus companies in last year – but what lies ahead?

Jul 19, 2021

Published by bit.bio

read more
United Nations High-Level Political Forum: Prioritizing Post-Pandemic Law and Governance Innovations for Just, Peaceful and Inclusive Societies

United Nations High-Level Political Forum: Prioritizing Post-Pandemic Law and Governance Innovations for Just, Peaceful and Inclusive Societies

Jul 15, 2021

Published by bit.bio

read more
Rethinking biology: coding cells for health - Davide Danovi | bit.bio’s Head of Cellular Phenotyping

Rethinking biology: coding cells for health - Davide Danovi | bit.bio’s Head of Cellular Phenotyping

Jun 29, 2021

Published by bit.bio

read more
bit.bio’s Founder and CEO Dr Mark Kotter discusses the uses of reprogrammed human cells in research and drug development

bit.bio’s Founder and CEO Dr Mark Kotter discusses the uses of reprogrammed human cells in research and drug development

Jun 29, 2021

Published by bit.bio

read more
How the building blocks of the body will revolutionise medicine

How the building blocks of the body will revolutionise medicine

Jun 29, 2021

Published by MoneyWeek

read more
The story of bit.bio on the Healthtech podcast

The story of bit.bio on the Healthtech podcast

Jun 10, 2021

Published by Healthtech podcast

read more
CEO and founder Mark Kotter interviewed on Spectator TV about cultured meat

CEO and founder Mark Kotter interviewed on Spectator TV about cultured meat

Jun 3, 2021

Published by Spectator TV

read more
bit.bio’s cell revolution looks to transform dementia treatments and grow organs to order

bit.bio’s cell revolution looks to transform dementia treatments and grow organs to order

May 20, 2021

Published by Daily Express

read more
Page 1 of 5 1 2 3 4 5